UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

The UK could be “less interesting” to pharma and life sciences firms after ... Roche is increasing its stock of medicines, in line with its peers, in the event of a no-deal Brexit, Schwan ...

In this article, we are going to take a look at where Kiniksa Pharmaceuticals International ... interesting developments for ...

Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma ...

On Tuesday, trading of Hepion Pharmaceuticals’ common stock continued on The Nasdaq Capital Market ... with Laidlaw & Company (UK) Ltd. acting as the sole placement agent. In financial disclosures, ...